Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Active as of 2021-11-04 |
<ActivityDefinition xmlns="http://hl7.org/fhir">
<id value="213"/>
<meta>
<versionId value="7"/>
<lastUpdated value="2023-12-05T12:52:51.103Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/recommendation-action"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b style="color: maroon">Exception generating Narrative: Error @1, 2: Premature ExpressionNode termination at unexpected token "=="</b></p></div>
</text>
<url value="https://fevir.net/resources/ActivityDefinition/213"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="213"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.40.44.11.1"/>
</identifier>
<version value="2.0.0-ballot"/>
<name value="IV_remdesivir_200_mg_then_100_mg_day_for_9_days"/>
<title value="IV remdesivir 200 mg then 100 mg/day for 9 days"/>
<status value="active"/>
<date value="2021-11-04T13:34:54.626Z"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="This example uses the Dosage datatype to represent dosing for IV remdesivir."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<relatedArtifact>
<type value="cite-as"/>
<citation
value="IV remdesivir 200 mg then 100 mg/day for 9 days [ActivityDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 213. Revised 2021-11-04. Available at: https://fevir.net/resources/ActivityDefinition/213. Computable resource at: https://fevir.net/resources/ActivityDefinition/213."/>
</relatedArtifact>
<kind value="MedicationRequest"/>
<code>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="2284960"/>
<display value="Remdesivir 100 mg Injection"/>
</coding>
</code>
<intent value="order"/>
<dosage>
<sequence value="1"/>
<text value="IV remdesivir 200 mg once on day 1"/>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="2"/>
</doseQuantity>
</doseAndRate>
</dosage>
<dosage>
<sequence value="2"/>
<text value="IV remdesivir 100 mg once daily on days 2 through 10"/>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="1"/>
</doseQuantity>
</doseAndRate>
</dosage>
</ActivityDefinition>